Center for Scientific Review; Notice of Closed Meetings, 32640-32641 [05-11084]
Download as PDF
<![CDATA[
32640
Federal Register / Vol. 70, No. 106 / Friday, June 3, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, SBIR/STTR
Study Section.
Date: June 16, 2005.
Time: 11 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Dan D. Gerendasy, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5132,
MSC 7843, Bethesda, MD 20892, 301–594–
6830, gerendad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Neuroepidemiology, Aging and
Musculoskeletal Epidemiology Member
Conflict.
Date: June 22, 2005.
Time: 6 p.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave, Bethesda, MD 20814.
Contact Person: Gertrude K. McFarland,
FAAN, RN, DNSC, Scientific Review
Administrator, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3156, MSC 7770, Bethesda, MD
20892, 301–435–1784, mcfarlag@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Clinical
Research and Field Studies.
Date: June 24, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Alexander D. Politis, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210,
MSC 7808, Bethesda, MD 20892, 301–435–
1150, politisa@csr.nih.gov.
VerDate jul<14>2003
18:03 Jun 02, 2005
Jkt 205001
Name of Committee: Center for Scientific
Review Special Emphasis Panel, ZRG1 GGG–
A (02)M: Transfer RNA Enzymes.
Date: June 24, 2005.
Time: 4 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard Panniers, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212,
MSC 7890, Bethesda, MD 20892, (301) 435–
1741, pannierr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Molecular
Oncogenesis.
Date: June 27–28, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Joanna M. Watson, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046–G,
MSC 7804, Bethesda, MD 20892, 301–435–
1048, watsonjo@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Microbial
Iron Metabolism.
Date: June 27, 2005.
Time: 9:30 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Rolf Menzel, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
MSC 7808, Bethesda, MD 20892, 301–435–
0952, menzelro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict in Speech Disorders and
Intervention.
Date: June 27, 2005.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Dana Jeffrey Plude, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7848, Bethesda, MD 20892, 301–435–
2309, pluded@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Neuro
Genetics.
Date: June 28–29, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select, 480 King Street,
Alexandria, VA 22314.
Contact Person: Robert C. Elliott, PhD,
Scientific Review Administrator, Center for
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–05–
028: Shared Instrumentation Imaging.
Date: June 28, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Hector Lopez, DSC,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5120,
MSC 7854, Bethesda, MD 20892, 301–435–
2392, lopezh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships; Biomedical Sensing and
Instrumentation.
Date: June 28, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Pushpa Tandon, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 7854, Bethesda, MD 20892, 301–435–
2397, tandoonp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Mechanism
of Tumorigenesis.
Date: June 28, 2005.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Zhiqiang Zou, MD, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, zouzhiq@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Imaging Technology.
Date: June 28, 2005.
Time: 7 p.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavillion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Robert J. Nordstrom, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5118,
MSC 7854, Bethesda, MD 20892, 301–435–
1175, nordstrr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Globin Gene
Transcription.
Date: June 30, 2005.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\03JNN1.SGM
03JNN1
Federal Register / Vol. 70, No. 106 / Friday, June 3, 2005 / Notices
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Chhanda L. Ganguly, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7802, Bethesda, MD 20892, 301–435–
1739, gangulyc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–11084 Filed 6–2–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://workplace.samhsa.gov
and https://www.drugfreeworkplace.gov.
VerDate jul<14>2003
18:03 Jun 02, 2005
Jkt 205001
Mrs.
Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs,
SAMHSA/CSAP, Room 2–1035, 1 Choke
Cherry Road, Rockville, Maryland
20857; 240–276–2600 (voice), 240–276–
2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Public Law
100–71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln
Ave., West Allis, WI 53227, 414–328–
7840 / 800–877–7016. (Formerly:
Bayshore Clinical Laboratory)
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624,
585–429–2264.
Advanced Toxicology Network, 3560
Air Center Cove, Suite 101, Memphis,
TN 38118, 901–794–5770 / 888–290–
1150.
Aegis Analytical Laboratories, Inc., 345
Hill Ave., Nashville, TN 37210, 615–
255–2400.
Baptist Medical Center—Toxicology
Laboratory, 9601 I–630, Exit 7, Little
Rock, AR 72205–7299, 501–202–2783.
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center)
Clinical Reference Lab, 8433 Quivira
Rd., Lenexa, KS 66215–2802, 800–
445–6917.
Diagnostic Services Inc., dba DSI, 12700
Westlinks Dr., Fort Myers, FL 33913,
239–561–8200 / 800–735–5416.
Doctors Laboratory, Inc., 2906 Julia
Drive, Valdosta, GA 31602, 229–671–
2281.
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
32641
DrugProof, Division of Dynacare/
Laboratory of Pathology, LLC, 1229
Madison St., Suite 500, Nordstrom
Medical Tower, Seattle, WA 98104,
206–386–2661 / 800–898–0180.
(Formerly: Laboratory of Pathology of
Seattle, Inc., DrugProof, Division of
Laboratory of Pathology of Seattle,
Inc.)
DrugScan, Inc., P.O. Box 2969, 1119
Mearns Rd., Warminster, PA 18974,
215–674–9310.
Dynacare Kasper Medical Laboratories *,
10150–102 St., Suite 200, Edmonton,
Alberta, Canada T5J 5E2, 780–451–
3702 / 800–661–9876.
ElSohly Laboratories, Inc., 5 Industrial
Park Dr., Oxford, MS 38655, 662–236–
2609.
Express Analytical Labs, 3405 7th Ave.,
Suite 106, Marion, IA 52302, 319–
377–0500.
General Medical Laboratories, 36 South
Brooks St., Madison, WI 53715, 608–
267–6225.
Kroll Laboratory Specialists, Inc., 1111
Newton St., Gretna, LA 70053, 504–
361–8989 / 800–433–3823, (Formerly:
Laboratory Specialists, Inc.)
LabOne, Inc., 10101 Renner Blvd.,
Lenexa, KS 66219, 913–888–3927 /
800–873–8845, (Formerly: Center for
Laboratory Services, a Division of
LabOne, Inc.)
Laboratory Corporation of America
Holdings, 7207 N. Gessner Rd.,
Houston, TX 77040, 713–856–8288 /
800–800–2387.
Laboratory Corporation of America
Holdings, 69 First Ave., Raritan, NJ
08869, 908–526–2400 / 800–437–
4986, (Formerly: Roche Biomedical
Laboratories, Inc.)
Laboratory Corporation of America
Holdings, 1904 Alexander Dr.,
Research Triangle Park, NC 27709,
919–572–6900 / 800–833–3984,
(Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of
Roche Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A
Member of the Roche Group.)
Laboratory Corporation of America
Holdings, 10788 Roselle St., San
Diego, CA 92121, 800–882–7272,
(Formerly: Poisonlab, Inc.)
Laboratory Corporation of America
Holdings, 1120 Main Street,
Southaven, MS 38671, 866–827–8042
/ 800–233–6339, (Formerly: LabCorp
Occupational Testing Services, Inc.;
MedExpress/National Laboratory
Center).
Marshfield Laboratories, Forensic
Toxicology Laboratory, 1000 North
Oak Ave., Marshfield, WI 54449, 715–
389–3734 / 800–331–3734.
E:\FR\FM\03JNN1.SGM
03JNN1
]]>Agencies
[Federal Register Volume 70, Number 106 (Friday, June 3, 2005)]
[Notices]
[Pages 32640-32641]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11084]
[[Page 32640]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, SBIR/STTR Study Section.
Date: June 16, 2005.
Time: 11 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Dan D. Gerendasy, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5132, MSC 7843, Bethesda, MD
20892, 301-594-6830, gerendad@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Neuroepidemiology, Aging and Musculoskeletal Epidemiology
Member Conflict.
Date: June 22, 2005.
Time: 6 p.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave,
Bethesda, MD 20814.
Contact Person: Gertrude K. McFarland, FAAN, RN, DNSC,
Scientific Review Administrator, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge Drive, Room 3156, MSC
7770, Bethesda, MD 20892, 301-435-1784, mcfarlag@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Clinical Research and Field Studies.
Date: June 24, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC
20037.
Contact Person: Alexander D. Politis, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD
20892, 301-435-1150, politisa@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, ZRG1 GGG-A (02)M: Transfer RNA Enzymes.
Date: June 24, 2005.
Time: 4 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Richard Panniers, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212, MSC 7890, Bethesda, MD
20892, (301) 435-1741, pannierr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Molecular Oncogenesis.
Date: June 27-28, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Joanna M. Watson, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046-G, MSC 7804, Bethesda, MD
20892, 301-435-1048, watsonjo@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Microbial Iron Metabolism.
Date: June 27, 2005.
Time: 9:30 a.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Rolf Menzel, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD
20892, 301-435-0952, menzelro@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict in Speech Disorders and Intervention.
Date: June 27, 2005.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Dana Jeffrey Plude, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7848, Bethesda, MD
20892, 301-435-2309, pluded@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Neuro Genetics.
Date: June 28-29, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Select, 480 King Street, Alexandria, VA
22314.
Contact Person: Robert C. Elliott, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130, MSC 7850, Bethesda, MD
20892, 301-435-3009, elliotro@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PAR-05-028: Shared Instrumentation Imaging.
Date: June 28, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave.,
Bethesda, MD 20814.
Contact Person: Hector Lopez, DSC, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5120, MSC 7854, Bethesda, MD
20892, 301-435-2392, lopezh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Fellowships; Biomedical Sensing and Instrumentation.
Date: June 28, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Pushpa Tandon, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104, MSC 7854, Bethesda, MD
20892, 301-435-2397, tandoonp@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Mechanism of Tumorigenesis.
Date: June 28, 2005.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190, MSC 7804, Bethesda, MD
20892, 301-451-0132, zouzhiq@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Fellowships: Imaging Technology.
Date: June 28, 2005.
Time: 7 p.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavillion, 4300
Military Road, NW., Washington, DC 20015.
Contact Person: Robert J. Nordstrom, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5118, MSC 7854, Bethesda, MD
20892, 301-435-1175, nordstrr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Globin Gene Transcription.
Date: June 30, 2005.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
[[Page 32641]]
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Chhanda L. Ganguly, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7802, Bethesda, MD
20892, 301-435-1739, gangulyc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-11084 Filed 6-2-05; 8:45 am]
BILLING CODE 4140-01-M
